Deanna Kerrigan
Deanna Kerrigan
M.P.H., Ph.D.
Professor and Chair of Prevention and Community Health
School: Milken Institute School of Public Health
Department: Prevention and Community Health
Contact:
Deanna Kerrigan is a social and behavioral scientist whose research over the last 25 years has focused on the role of socio-structural factors that shape the health of underserved groups. She has led multiple NIH-funded studies to develop community-driven interventions including for marginalized women at heightened risk for HIV infection in Latin America and the Caribbean and sub-Saharan Africa. These interventions have been recognized as international best practice models for community empowerment-based HIV prevention and have been highlighted in World Health Organization, UNAIDS, UNFPA and World Bank reports, technical guidelines and implementation tools.
Dr. Kerrigan is Professor and Chair of the Department of Prevention and Community Health at the Milken Institute School of Public Health at George Washington (GW) University. She is on the Executive Committee of the DC Center for AIDS Research (CFAR) and was previously the Co-Director of the Prevention Core of the Johns Hopkins University (JHU) CFAR. Before joining GW, Dr. Kerrigan was Professor of Sociology and Director of the Center on Health, Risk and Society (CHRS) at American University and was on faculty at the Johns Hopkins Bloomberg School of Public Health for 15 years. At JHU, she directed a large-scale USAID-funded, global HIV prevention implementation science portfolio, Research to Prevention (R2P) that spanned 18 countries. Dr. Kerrigan also previously served as a Program Officer for the Ford Foundation in Brazil.
Community Health
Prevention
Social Determinants of Health
Global Health
Underserved Populations
HIV/AIDS
Women's Health
Bachelor of Arts, Political Science and Spanish, Emory University, 1991.
Master of Public Health, Health Education and Communication/International Health, Tulane School of Public Health and Tropical Medicine, 1992.
Doctor of Philosophy, Social and Behavioral Interventions/International Health, Johns Hopkins Bloomberg School of Public Health, 2000.
Dr. Kerrigan has served as the principal or co-principal investigator on multiple NIH-funded studies including:
Stigma, cohesion and HIV outcomes among vulnerable women across geographic settings (R01MH110158);
Integrating PrEP into an effective community-driven model of HIV prevention among Tanzanian women at high risk (R01MH110158S)
Assessing social dynamics of HIV outcomes to inform interventions with transgender women living with HIV in the Dominican Republic (R01MH110158S)
Patient and provider perspectives on long-acting injectable ART in the United States (R01MH118955);
Community-based combination HIV prevention among Tanzanian women at heightened risk (R01MH104044).
Select first author publications from the past 5 years are listed below:
Kerrigan D, Sanchez Karver T, Muraleetharan O, Savage V, Mbwambo J, Donastorg Y, Likindikoki S, Perez M, Gomez H, Mantsios A, Murray M, Beckham SW, Davis W, Galai N, Barrington C. "A dream come true": Perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania. PLoS One. 2020 Jun 12;15(6):e0234666.
Kerrigan D, Donastorg Y, Barrington C, Perez M, Gomez H, Mbwambo J, Likindikoki S, Mantsios A, Beckham SW, Leddy A, Karver TS, Galai N, Davis WW. Assessing and Addressing Social Determinants of HIV among Female Sex Workers in the Dominican Republic and Tanzania through Community Empowerment-Based Responses. Curr HIV/AIDS Rep. 2020 Feb 18.
Kerrigan D, Mbwambo J, Likindikoki S, Davis W, Mantsios A, Beckham SW, Leddy A, Shembilu C, Mwampashi A, Aboud S, Galai N. Project Shikamana: a community empowerment model of combination prevention significantly impacts HIV incidence and care continuum outcomes among female sex workers in Iringa, Tanzania. J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):141-148.
Kerrigan D, Grieb S, Ellen J, Sibinga S. Exploring the dynamics of ART adherence in the context of a mindfulness instruction intervention among youth living with HIV in Baltimore, Maryland. AIDS Care. AIDS Care. 2018 Jul 1:1-6.
Kerrigan D, Tudor C, Motlhaoleng K, Lebina L, Qomfu C, Variava E, Chon S, Martinson N, Golub JE. Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial. BMC Health Serv Res. 2018 Apr 16;18(1):288.
Kerrigan D, Mantsios A, Gorgolas M, Montes ML, Pulido F, Brinson C, deVente J, Richmond GJ, Beckham SW, Hammond P, Margolis D, Murray M. Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain. PLoS One. 2018 Jan 5;13(1):e0190487.
Kerrigan D, Mantsios A, Grant R, Markowitz M, Defechereux P, La Mar M, Beckham SW, Hammond P, Margolis D, Murray M. Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. AIDS Behav. 2017 Dec 30.
Kerrigan D, King M, Chau V, Holman E, Joffe A, Sibinga E. There is no performance, there is just this moment: the role of mindfulness instruction in promoting health and well-being among students at a highly-ranked university in the United States. J Evid Based Complementary Altern Med. 2017 Oct;22(4):909-918.
Kerrigan D, West N, Tudor C, Hanrahan CF, Lebina L, Msandiwa R, Mmolawa L, Martinson N, Dowdy D. Improving active case finding for tuberculosis in South Africa: informing innovative implementation approaches in the context of the Kharitode trial through formative research. Health Res Policy Syst. 2017 May 30;15(1):42.
Kerrigan, D, Mbwambo J, Likindikoki S, Beckham S, Mwampashi A, Shembilu C, Mantsios A, Leddy A, Davis, W, Galai N. Project Shikamana: Baseline findings from a community empowerment based combination HIV prevention trial among female sex workers in Iringa, Tanzania. J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S60-S68.
Kerrigan D, Barrington C, Donastorg Y, Perez M, Galai N. Abriendo Puertas: Feasibility and Effectiveness a Multi-Level Intervention to Improve HIV Outcomes Among Female Sex Workers Living with HIV in the Dominican Republic. AIDS Behav. 2016 Mar 25.
Kerrigan D, Kennedy CE, Cheng AS, Sandison SJ, Fonner VA, Holtgrave DR, Brahmbhatt H. Advancing the strategic use of HIV operations research to strengthen local policies and programmes: the Research to Prevention Project. J Int AIDS Soc. 2015 Aug 18;18(1):20029.
Kerrigan D, Vazzano A, Malta M, Bertoni N, Bastos FI. Stigma, discrimination and HIV outcomes among people living with HIV in Rio de Janeiro, Brazil: the intersection of multiple social inequalities. Glob Public Health. 2015 Aug 10:1-15.
Kerrigan D, Kennedy CE, Morgan-Thomas R, Reza-Paul S, Mwangi P, Win KT, McFall A, Fonner VA, Butler J. A community empowerment approach to the HIV response among sex workers: effectiveness, challenges, and considerations for implementation and scale-up. Lancet. 2015 Jan 10;385(9963):172-85.